Delivery Order SPE2DR25D1053-SPE2DR26FT116
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for the supply of Orserdu 345 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was issued on September 16, 2025, with an ultimate completion date of October 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. The delivery order operates as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award was issued on July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,954.56 for ORSERDU 345 mg tablets (30-count) on October 20, 2025, with completion scheduled for November 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $69,604.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Orserdu 345 mg tablets (30-count units). The contract, which is a non-set-aside competitive award, will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 8, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Orserdu 345 mg tablets (30-count packages) with a ceiling value of $27,841.82. This firm fixed-price delivery order, which is scheduled for completion by October 6, 2025, carries no set-aside designation and represents a competitively awarded contract. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for ORSERDU 345 mg tablets (30-count supply) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $13,929.10 for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and is not designated as a set-aside contract. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency for the supply of Attruby 356 mg tablets (28-count packages) with a firm fixed price structure. The award, made on May 8, 2025, carries an ultimate completion date of May 30, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,364.48 to AmerisourceBergen Drug Corp on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT116Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,547.52 to AmerisourceBergen Drug Corp for the supply of Orserdu 86 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award, issued on October 20, 2025, with completion scheduled for November 10, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a diverse portfolio of medications and medical commodities including specialty drugs, brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic areas. The company's consistent success in competitive federal procurement demonstrates its capability to meet stringent medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 10/20/25 |